FDA Panel To Review Pfizer Vaccine For Children
Interactive Video
•
Social Studies
•
University
•
Hard
Wayground Content
FREE Resource
The video discusses an FDA panel meeting to review Pfizer's COVID-19 vaccine for children aged 5 to 11, highlighting its 90% efficacy against symptomatic disease. The process involves FDA recommendations, followed by CDC guidance. The White House plans to distribute vaccines through pediatricians, hospitals, and schools. Despite most parents willing to vaccinate their children, some hesitancy remains, with polls indicating that mandates or full FDA approval could influence decisions.
Read more
1 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What new insight or understanding did you gain from this video?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
